! The Capitol Complex is closed to the public due to COVID-19. All meetings will be held virtually online. View procedures and guidelines (PDF) for remote public comment and virtual meeting instructions (PDF).

Download Zipped Enrolled WordPerfect HB0128.ZIP
[Introduced][Amended][Status][Bill Documents][Fiscal Note][Bills Directory]

H.B. 128 Enrolled

             1     

ELECTRONIC PRESCRIBING ACT

             2     
2009 GENERAL SESSION

             3     
STATE OF UTAH

             4     
Chief Sponsor: Ronda Rudd Menlove

             5     
Senate Sponsor: Peter C. Knudson

             6      Cosponsor:Evan J. Vickers              7     
             8      LONG TITLE
             9      General Description:
             10          This bill enacts the Electronic Prescribing Act within Title 58, Occupations and
             11      Professions.
             12      Highlighted Provisions:
             13          This bill:
             14          .    defines terms;
             15          .    requires a practitioner to provide each existing patient of the practitioner with the
             16      option to participate in electronic prescribing, if the practitioner prescribes a drug
             17      or device for the patient on or after July 1, 2012;
             18          .    provides that a practitioner may not issue a prescription through electronic
             19      prescribing for a drug or device that the practitioner is prohibited by federal law or
             20      federal rule from issuing through electronic prescribing;
             21          .    requires a pharmacy to accept and comply with an electronic prescription that is
             22      transmitted in accordance with the requirements of this section and rules made by
             23      the Division of Occupational and Professional Licensing; and
             24          .    grants rulemaking authority to the Division of Occupational and Professional
             25      Licensing to:
             26              .    enforce the provisions of this bill;
             27              .    ensure that electronic prescribing is done in a secure manner, consistent with
             28      industry standards;
             29              .    ensure that each patient is fully informed of the patient's rights, restrictions, and


             30      obligations pertaining to electronic prescribing; and
             31              .    grant a hardship exemption to a pharmacy or a practitioner, to the extent that
             32      the requirements of this bill would impose an extreme financial hardship on the
             33      pharmacy or the practitioner.
             34      Monies Appropriated in this Bill:
             35          None
             36      Other Special Clauses:
             37          This bill takes effect on July 1, 2012.
             38      Utah Code Sections Affected:
             39      ENACTS:
             40          58-78-101, Utah Code Annotated 1953
             41          58-78-102, Utah Code Annotated 1953
             42          58-78-201, Utah Code Annotated 1953
             43     
             44      Be it enacted by the Legislature of the state of Utah:
             45          Section 1. Section 58-78-101 is enacted to read:
             46     
CHAPTER 78. ELECTRONIC PRESCRIBING ACT

             47     
Part 1. General Provisions

             48          58-78-101. Title.
             49          This chapter is known as the "Electronic Prescribing Act."
             50          Section 2. Section 58-78-102 is enacted to read:
             51          58-78-102. Definitions.
             52          As used in this chapter:
             53          (1) "Drug" is as defined in Section 58-37-2 .
             54          (2) "Electronic prescribing" means the electronic generation and transmission of a
             55      prescription between a practitioner and a pharmacy.
             56          (3) "Existing patient" means a person who a practitioner has:
             57          (a) obtained information regarding, in the usual course of professional practice, that is


             58      sufficient to:
             59          (i) establish a diagnoses;
             60          (ii) identify conditions; and
             61          (iii) identify contraindications to potential treatment; and
             62          (b) accepted as a patient.
             63          (4) (a) "Federal controlled substance" means a drug or substance included in
             64      Schedules I, II, III, IV, or V of the federal Controlled Substances Act, Title II, P.L. 91-513, or
             65      any federal controlled substance analog.
             66          (b) "Federal controlled substance" does not include:
             67          (i) distilled spirits, wine, or malt beverages, as those terms are defined or used in Title
             68      32A, Alcoholic Beverage Control Act, regarding tobacco or food;
             69          (ii) any drug intended for lawful use in the diagnosis, cure, mitigation, treatment, or
             70      prevention of disease in man or other animals, which contains ephedrine, pseudoephedrine,
             71      norpseudoephedrine, or phenylpropanolamine if the drug is lawfully purchased, sold,
             72      transferred, or furnished as an over-the-counter medication without prescription; or
             73          (iii) dietary supplements, vitamins, minerals, herbs, or other similar substances
             74      including concentrates or extracts, which are not otherwise regulated by law, which may
             75      contain naturally occurring amounts of chemicals or substances listed in this chapter, or in
             76      rules adopted pursuant to Title 63G, Chapter 3, Utah Administrative Rulemaking Act.
             77          (5) (a) "Federal controlled substance analog" means a substance the chemical structure
             78      of which is substantially similar to the chemical structure of a controlled substance listed in
             79      Schedules I and II of the federal Controlled Substances Act, Title II, P.L. 91-513:
             80          (i) which has a stimulant, depressant, or hallucinogenic effect on the central nervous
             81      system substantially similar to the stimulant, depressant, or hallucinogenic effect on the central
             82      nervous system of controlled substances in the schedules set forth in Subsection (4); or
             83          (ii) which, with respect to a particular individual, is represented or intended to have a
             84      stimulant, depressant, or hallucinogenic effect on the central nervous system substantially
             85      similar to the stimulant, depressant, or hallucinogenic effect on the central nervous system of


             86      controlled substances in the schedules set forth in Subsection (4).
             87          (b) "Federal controlled substance analog" does not include:
             88          (i) a controlled substance currently scheduled in Schedules I through V of Section
             89      58-37-4 ;
             90          (ii) a substance for which there is an approved new drug application;
             91          (iii) a substance with respect to which an exemption is in effect for investigational use
             92      by a particular person under Section 505 of the Food, Drug, and Cosmetic Act, 21 U.S.C. 355,
             93      to the extent the conduct with respect to the substance is permitted by the exemption;
             94          (iv) any substance to the extent not intended for human consumption before an
             95      exemption takes effect with respect to the substance;
             96          (v) any drug intended for lawful use in the diagnosis, cure, mitigation, treatment, or
             97      prevention of disease in man or other animals, which contains ephedrine, pseudoephedrine,
             98      norpseudoephedrine, or phenylpropanolamine if the drug is lawfully purchased, sold,
             99      transferred, or furnished as an over-the-counter medication without prescription; or
             100          (vi) dietary supplements, vitamins, minerals, herbs, or other similar substances
             101      including concentrates or extracts, which are not otherwise regulated by law, which may
             102      contain naturally occurring amounts of chemicals or substances listed in this chapter, or in
             103      rules adopted pursuant to Title 63G, Chapter 3, Utah Administrative Rulemaking Act.
             104          (6) "Pharmacy" is as defined in Section 58-17b-102 .
             105          (7) "Practitioner" means an individual currently licensed, registered, or otherwise
             106      authorized by the state to prescribe and administer a drug in the course of professional
             107      practice.
             108          (8) "Prescription" is as defined in Section 58-37-2 .
             109          Section 3. Section 58-78-201 is enacted to read:
             110     
Part 2. Electronic Prescribing

             111          58-78-201. Electronic prescriptions -- Restrictions -- Rulemaking authority.
             112          (1) Subject to the provisions of this section, a practitioner shall provide each existing
             113      patient of the practitioner with the option of participating in electronic prescribing for


             114      prescriptions issued for the patient, if the practitioner prescribes a drug or device for the
             115      patient on or after July 1, 2012.
             116          (2) A practitioner may not issue a prescription through electronic prescribing for a
             117      drug, device, or federal controlled substance that the practitioner is prohibited by federal law
             118      or federal rule from issuing through electronic prescribing.
             119          (3) A pharmacy shall:
             120          (a) accept an electronic prescription that is transmitted in accordance with the
             121      requirements of this section and division rules; and
             122          (b) dispense a drug or device as directed in an electronic prescription described in
             123      Subsection (3)(a).
             124          (4) The division shall make rules to ensure that:
             125          (a) except as provided in Subsection (5), practitioners and pharmacies comply with
             126      this section;
             127          (b) electronic prescribing is conducted in a secure manner, consistent with industry
             128      standards; and
             129          (c) each patient is fully informed of the patient's rights, restrictions, and obligations
             130      pertaining to electronic prescribing.
             131          (5) The division may, by rule, grant an exemption from the requirements of this
             132      section to a pharmacy or a practitioner to the extent that the pharmacy or practitioner can
             133      establish, to the satisfaction of the division, that compliance with the requirements of this
             134      section would impose an extreme financial hardship on the pharmacy or practitioner.
             135          Section 4. Effective date.
             136          This bill takes effect on July 1, 2012.


[Bill Documents][Bills Directory]